View by Specialty

Trending

Image: Healio
September 20, 2024
1 min read
Save

FDA approves nasal spray as first self-administered flu vaccine

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 04, 2023
1 min read
Save

Partnership to develop gene editing therapies for neurological, muscular diseases

Partnership to develop gene editing therapies for neurological, muscular diseases

Regeneron Pharmaceuticals Inc. and Intellia Therapeutics Inc. have announced an expanded research collaboration intended to develop additional CRISPR-based gene editing therapies focused on neurological and muscular diseases.

SPONSORED CONTENT
October 04, 2023
2 min read
Save

Use of AI software led to improved outcomes for those with intracranial hemorrhage

Use of AI software led to improved outcomes for those with intracranial hemorrhage

Use of artificial intelligence triage software led to a significant reduction in 30- and 120-day all-cause mortality for those with intracranial hemorrhage compared with those treated without the algorithm, according to research.

Trending

Image: Healio
September 20, 2024
1 min read
Save

FDA approves nasal spray as first self-administered flu vaccine

SPONSORED CONTENT
October 03, 2023
1 min read
Save

FDA removes partial clinical hold on IND for rare pediatric disease drug-device combo

FDA removes partial clinical hold on IND for rare pediatric disease drug-device combo

A Bay Area biotech company announced the FDA has lifted the partial clinical hold on EryDel SpA’s investigational new drug application for EryDex to treat ataxia-telangiectasia, a rare pediatric neurological disorder.

SPONSORED CONTENT
October 03, 2023
2 min read
Save

Continuous subcutaneous foslevodopa/foscarbidopa improved PD symptoms at 1 year

Continuous subcutaneous foslevodopa/foscarbidopa improved PD symptoms at 1 year

Continuous subcutaneous infusion of foslevodopa/foscarbidopa improved “on” time and reduced “off” time in those with Parkinson’s disease at 52 weeks, with a favorable safety and tolerability profile, per research from Neurology and Therapy.

SPONSORED CONTENT
October 02, 2023
2 min read
Save

Speaker offers advice on how to achieve goals through inspiration, not end result

Speaker offers advice on how to achieve goals through inspiration, not end result

Goal setting should be centered around purpose, action plans and motivation rather than the achievement alone, a presenter at the Women in Medicine Summit explained.

SPONSORED CONTENT
October 02, 2023
3 min read
Save

Electrical stimulation to the tongue can help treat gait deficit symptoms in MS

Electrical stimulation to the tongue can help treat gait deficit symptoms in MS

As a neuro clinical specialist in physical therapy, I treat many people with multiple sclerosis.

SPONSORED CONTENT
October 02, 2023
4 min read
Save

Q&A: Online health care prices often 'wildly different' from estimates offered over phone

Q&A: Online health care prices often 'wildly different' from estimates offered over phone

Price transparency is considered a step in the right direction when it comes to taming health care costs, but researchers have found that prices for certain hospital services can differ — often wildly — from what is presented.

SPONSORED CONTENT
October 02, 2023
1 min read
Save

FDA accepts IND with partial clinical hold for oral small molecule Alzheimer’s treatment

FDA accepts IND with partial clinical hold for oral small molecule Alzheimer’s treatment

The FDA has accepted an investigational new drug application for VG-3927, an oral small molecule TREM2 agonist for the potential treatment of Alzheimer’s disease, according to the manufacturer.

SPONSORED CONTENT
October 02, 2023
4 min read
Save

Four tools that provide both asset protection and tax benefits

Four tools that provide both asset protection and tax benefits

As an orthopedic surgeon and an attorney/wealth manager who has worked with more than 1,000 physicians, we know that asset protection and tax planning are two of the highest interest planning areas for physicians.

SPONSORED CONTENT
October 02, 2023
4 min read
Save

Electrical stimulation may reduce OSA severity in patients with low CPAP adherence

Electrical stimulation may reduce OSA severity in patients with low CPAP adherence

In patients with obstructive sleep apnea and poor CPAP adherence, domiciliary transcutaneous electrical stimulation for 3 months improved disease severity compared with CPAP, according to results published in eClinicalMedicine.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails